Biomarkers and Pathology

One imperative part of the part of Pathology in the assessment of bosom malignancy is biomarker trying, particularly the precise appraisal of the estrogen receptor (ER), progesterone receptor (PR), and Her2 status of a patient's bosom tumor. Biomarkers can be prognostic, prescient, or both. Prognostic biomarkers are free measures of forecast to such an extent that the nearness or nonappearance of the biomarker is connected with a patient's general clinical result (i.e., danger of repeat and mortality).

  • Molecular Pathology
  • Clinical Pathology
  • Clinical Pathology

Related Conference of Biomarkers and Pathology

October 18-20, 2017

10th World Congress on Biomarkers & Clinical Research

Baltimore, USA
November 13-15,2017

17th World Fitness Expo

(10 Plenary Forums - 1Event) Atlanta, USA
December 07-08, 2017

29th World Psychiatrists Meet

Dubai, UAE
March 22-24, 2018

Annual Physicians Meeting 2018

Dubai, UAE
April 16-17, 2018

World Congress on Gynecology and Obstetrics

April 16-17, 2018
April 23-24, 2018

International Conference on Internal Medicine

Dubai, UAE
June 21-22, 2018

3rd International Conference on Anesthesia 2018

Dublin, Ireland
September 24-25, 2018

9th International Conference on Clinical & Medical Case Reports

| Amsterdam, Netherlands
October 15-16, 2018

Annual congress on Research and Innovations in Medicine

Seoul, South Korea

Biomarkers and Pathology Conference Speakers